Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Biomolecules|May 27, 2023
Special Issue "Role of NRF2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches II"Isabel Lastres-BeckerBiomolecules|February 5, 2021
Special Issue "Role of NRF2 in Disease: Novel Molecular Mechanisms and Therapeutic Approaches"Isabel Lastres-BeckerCurrent Medicinal Chemistry|December 16, 2006
An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatmentsIsabel Lastres-Becker, Javier Fernández-RuizRedox Biology|November 10, 2017
Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathyAntonio Cuadrado, Sebastian Kügler, Isabel Lastres-BeckerCerebellum (London, England)|April 18, 2008
Spinocerebellar ataxia 2 (SCA2)Isabel Lastres-Becker, Udo Rüb, Georg AuburgerCurrent Opinion in Neurology|April 11, 2009
Role of microglial redox balance in modulation of neuroinflammationNadia G Innamorato, Isabel Lastres-Becker, Antonio CuadradoAntioxidants (Basel, Switzerland)|August 26, 2023
Aging, NRF2, and TAU: A Perfect Match for Neurodegeneration?Mirjam Brackhan, Marina Arribas-Blazquez, Isabel Lastres-BeckerJournal of Neuroimmunology|January 28, 2006
Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1beta and TNF-alphaIsabel Lastres-Becker, Tam Cartmell, Francisco Molina-HolgadoNeurological Research and Practice|December 16, 2020
New alternative splicing variants of the ATXN2 transcriptIsabel Lastres-Becker, David Nonis, Joachim Nowock, et al.Neurobiology of Disease|May 21, 2026
Analysisoftheinvolvementof RNA-bindingproteinsintau-dependentneurodegenerationIgnacio Silva-Llanes, Pablo Baceiredo-Macho, Isabel Lastres-BeckerPageof 6